Charles River Laboratories International, Inc. News Headlines

CRL 
$59.11
*  
0.09
0.15%
Get CRL Alerts
*Delayed - data as of Aug. 22, 2014  -  Find a broker to begin trading CRL now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Update: Charles River Labs Earnings
8/20/2014 1:40:00 PM - Seeking Alpha

Novo Nordisk to Pay Fine, Tresiba in Focus - Analyst Blog
8/19/2014 5:50:00 PM - Zacks.com

Why Charles River Laboratories International (CRL) Could Beat Earnings Estimates Again - Tale of the Tape
8/18/2014 8:49:00 AM - Zacks.com

Merck's Insomnia Drug Belsomra Approved by the FDA - Analyst Blog
8/14/2014 5:00:00 PM - Zacks.com

Cramer's Mad Money - These 2 Sectors Have A Huge Void (8/12/14)
8/13/2014 6:09:00 AM - Seeking Alpha

Charles River Laboratories Investor Meeting Webcast At 8:30 AM ET
8/12/2014 7:30:00 AM - RTT News

Parexel - Best CRO, But Wait For A Better Moment
8/11/2014 10:24:00 AM - Seeking Alpha

Dynavax Technologies Q2 Loss Wider than Expected, Sales Beat - Analyst Blog
8/8/2014 4:22:00 PM - Zacks.com

Charles River Laboratories (CRL) Jumps: Stock Moves 5% Higher - Tale of the Tape
8/8/2014 9:25:00 AM - Zacks.com

Charles River Beats on Q2 Earnings & Revenues, Outlook Upped - Analyst Blog
8/7/2014 2:10:00 PM - Zacks.com

Charles River Laboratories International At 9:00 AM ET
8/7/2014 8:03:00 AM - RTT News

Charles River Q2 Results Top Estimates
8/6/2014 8:03:00 PM - RTT News

Acorda Beats on Q2 Earnings & Revenues, Maintains View - Analyst Blog
8/4/2014 9:20:00 AM - Zacks.com

MedAssets to Help Centegra Health System Build ACO Model - Analyst Blog
7/15/2014 6:13:00 PM - Zacks.com

Progenics-Salix Up on Encouraging Relistor News - Analyst Blog
7/15/2014 4:45:00 PM - Zacks.com

Cramer's Mad Money - Piggyback On Peltz (7/14/14)
7/15/2014 6:00:00 AM - Seeking Alpha

Allergan Slides as Migraine Drug Fails to Win Approval - Analyst Blog
7/1/2014 4:30:00 PM - Zacks.com

Charles River Laboratories International Breaks Above 200-Day Moving Average - Bullish for CRL
7/1/2014 11:41:26 AM - BNK Invest

Charles River To Present At William Blair Conference; Webcast At 11:40 AM ET
6/11/2014 10:40:00 AM - RTT News

Valeant's Jublia Approved in the U.S. - Analyst Blog
6/10/2014 5:50:00 PM - Zacks.com

Charles River To Present At Jefferies Conference ; Webcast At 11:00 AM ET
6/3/2014 10:00:00 AM - RTT News

Sanofi's Lemtrada Accepted for FDA Review - Analyst Blog
6/2/2014 7:14:00 PM - Zacks.com

InterMune Resubmits Esbriet NDA - Analyst Blog
5/28/2014 6:18:00 PM - Zacks.com

EU Nod for Eli Lilly/Boehringer's Jardiance (revised) - Analyst Blog
5/28/2014 2:26:32 PM - Zacks.com

CHMP Negative on Novartis' RLX030 - Analyst Blog
5/27/2014 6:15:00 PM - Zacks.com